Search

STERIS PLC

Slēgts

SektorsVeselības aprūpe

230.64 -0.97

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

231.86

Max

233.48

Galvenie mērījumi

By Trading Economics

Ienākumi

-19M

201M

Pārdošana

-96M

1.5B

P/E

Sektora vidējais

29.065

57.002

EPS

2.59

Dividenžu ienesīgums

1.06

Peļņas marža

13.466

Darbinieki

17,937

EBITDA

-331M

349M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+16.31% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

1.06%

2.22%

Nākamie ieņēmumi

2026. g. 4. nov.

Nākamais dividenžu datums

2026. g. 25. sept.

Nākamais Ex dividenžu datums

2026. g. 3. sept.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1B

23B

Iepriekšējā atvēršanas cena

231.61

Iepriekšējā slēgšanas cena

230.64

Ziņu noskaņojums

By Acuity

50%

50%

146 / 340 Rangs Healthcare

STERIS PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 14. aug. 22:01 UTC

STERIS plc shares are lower in after-market hours amid concerns about consumer sentiment following an unexpected drop in U.S. retail sales for July.

2026. g. 13. aug. 23:46 UTC

STERIS plc shares are lower in after-market hours, continuing a trend of declines since Thursday's close. No specific news was identified to explain the move.

2026. g. 12. aug. 20:06 UTC

News

STERIS plc shares are lower as first-quarter results show a modest decline. The company announced a $600 million investment in a new manufacturing center.

2026. g. 11. aug. 20:01 UTC

Shares of STERIS plc are lower today, breaking a recent trend of higher daily closes. No specific news was identified for the decline.

2026. g. 10. aug. 19:43 UTC

News
Correlated Moves

STERIS shares are trading higher as Piper Sandler raised its price target to $275, despite mixed analyst ratings and target adjustments from UBS and KeyCorp.

2026. g. 7. aug. 20:02 UTC

News

Piper Sandler raised STERIS plc's price target to $275, supporting positive sentiment. The stock advanced after earlier session weakness, reflecting strong buying interest.

2026. g. 6. aug. 20:03 UTC

News

STERIS plc reported Q2 sales of $1.49 billion and adjusted EPS of $2.59, exceeding expectations. Shares are lower despite the results amid high trading volume.

2026. g. 5. aug. 22:02 UTC

News

STERIS plc shares lower in after-market hours as FY2027 EPS guidance widens, missing estimates, and first-quarter sales fall short of expectations.

2026. g. 4. aug. 20:07 UTC

News

STERIS shares are higher today, supported by broader market trends and a decline in crude oil prices. Earnings results are due August 5, 2026.

2026. g. 3. aug. 20:06 UTC

News

STERIS plc shares are higher ahead of its Q1 2027 earnings announcement. Analysts expect earnings of $2.49 per share and revenue of $1.4949 billion.

2026. g. 31. jūl. 19:26 UTC

Social Media
News

Shares of STERIS plc are lower despite a dividend increase announcement. UBS initiated coverage with a buy rating and a target price of $275.

2026. g. 30. jūl. 18:51 UTC

STERIS plc is lower today, driven by weakness in the Health Care Equipment sub-sector. The stock reached a session low earlier this morning.

2026. g. 29. jūl. 20:08 UTC

Shares of STERIS plc are higher today, supported by overall market strength and notable gains in oil prices amid escalating geopolitical tensions.

2026. g. 28. jūl. 20:13 UTC

STERIS plc shares are trading higher in after-market hours, continuing a trend of gains and remaining significantly above the 20-day moving average.

2026. g. 27. jūl. 20:06 UTC

STERIS plc shares are higher today, reflecting gains since Friday's close, despite pulling back from an earlier session high. No specific news was identified.

2026. g. 24. jūl. 18:06 UTC

STERIS plc shares are higher during Friday's session, having reached an early peak. No specific company news was identified to explain the movement.

2026. g. 21. jūl. 19:06 UTC

STERIS plc is declining as Health Care Equipment sub-sector weakness weighs on shares during Tuesday's session amid unusual volatility and significant sector downward movement.

2026. g. 20. jūl. 18:41 UTC

STERIS plc shares are lower today, continuing a downward trend since Friday. The stock remains near the upper end of its one-month trading range.

Salīdzinājums

Cenas izmaiņa

STERIS PLC Prognoze

Cenas mērķis

By TipRanks

16.31% augšup

Prognoze 12 mēnešiem

Vidējais 271.33 USD  16.31%

Augstākais 275 USD

Zemākais 269 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi STERIS PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

3

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

146 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat